Data & Analytics VC Funds

Anzu Partners is a venture capital firm founded in 2014, focusing on breakthrough industrial and life sciences technologies. Headquartered in Washington, D.C., with additional offices in Boston, San Diego, and Tampa, the firm manages over $1 billion in strategic assets across various funds and investment strategies. Anzu Partners has a robust portfolio of around 40 companies, including notable investments in e-Zinc, Framework, EnCharge, AM Batteries, and Arduino. The firm has also achieved significant exits, such as NUBURU and Ai-Media, highlighting its capability to support companies from early stages through to successful public offerings or acquisitions. Anzu specializes in three primary investment solutions: venture capital investments, debt and revenue-based investments, and Special Purpose Acquisition Companies (SPACs). The firm provides not just capital but also deep expertise in business development, market positioning, global connectivity, and operations, helping to drive the commercial success of its portfolio companies. The leadership team at Anzu Partners includes experienced professionals like Managing Partners David Michael, David Seldin, and Whitney Haring-Smith, who bring decades of combined experience in global investments and consultancy. This expertise is further supported by a dedicated team of technical and operational professionals.

AP Capital is a diversified investment firm with a strong presence in global markets, including equities, commodities, foreign exchange, and fixed income. Headquartered in Asia and Los Angeles, the firm specializes in proprietary trading and asset management. AP Capital aims to achieve consistent net-positive returns while minimizing market risks, making it a go-to choice for high-net-worth individuals, family offices, and institutional investors across Asia, Europe, and North America. The firm's investment strategy emphasizes a low correlation to broader market fluctuations, leveraging cutting-edge technology for its trading operations. AP Capital offers discretionary fund products and managed accounts, allowing investors greater transparency and control over their portfolios. Their diverse approach spans multiple industries, including real estate, renewable energy, and tech. With a focus on risk-adjusted returns and liquidity improvement, AP Capital has built a reputation for being nimble and adaptable, thanks to its young, energetic, and meritocratic team culture.

Apax Partners is a leading global private equity advisory firm with a focus on inspiring growth and transforming businesses. Founded nearly 50 years ago, Apax has raised and advised over 30 funds, managing more than $77 billion in aggregate capital. The firm primarily invests in four sectors: Tech, Services, Healthcare, and Internet/Consumer. Apax operates several strategic funds, including Apax Global Buyout, which focuses on transformative growth in key sectors, and Apax Digital Growth, aimed at accelerating tech companies. Additionally, Apax Global Impact targets companies that deliver tangible societal and environmental benefits, while Apax Mid-Market Israel leverages local expertise to support growth in Israeli businesses. The firm also has Apax Credit and Apax Listed Private Equity strategies to provide a flexible investment approach across the capital structure​. Notable investments include Auto Trader Group, GlobalLogic, and Cole Haan, among others. Apax leverages its deep sector expertise and global network to drive operational excellence and digital transformation within its portfolio companies. The firm’s extensive experience and strategic focus have made it a prominent player in private equity globally, with offices in major financial hubs including London, New York, Hong Kong, and Tel Aviv​.

Aperture Venture Capital (Aperture VC) is a venture capital firm founded in 2021, based in Radnor, Pennsylvania. The firm focuses on investing in early-stage companies, particularly those led by diverse founders who are building the future of fintech and enterprise software. Aperture VC's mission is to redefine the venture capital landscape by supporting the "Multicultural Mainstream," which includes Black, Latinx, and female entrepreneurs. Aperture VC’s unique approach involves its Diversity Investing API℠, a platform designed to connect corporate partners with diverse talent and market innovations. This platform also provides portfolio companies with critical operating resources to help them scale. The firm believes that by investing in diverse founders, they can unlock untapped potential and drive significant impact in the venture capital ecosystem. Aperture VC has quickly gained recognition in the industry, attracting investments from major corporations like PayPal, which have recognized the value of supporting diverse founders. The firm is committed to fostering an inclusive ecosystem where diverse entrepreneurs can thrive and achieve successful exits.

APEX Ventures is a venture capital firm based in Vienna, Austria, specializing in deep tech and medical technology startups. Founded in 2016, APEX Ventures invests in early-stage companies across Europe, with a focus on innovations in AI, quantum computing, automation, robotics, computer vision, space technology, and medical technology. The firm emphasizes backing startups with unique, defensible technologies that have the potential to disrupt and transform their respective industries​. In 2023, APEX Ventures partnered with Amadeus Capital Partners to launch the Amadeus APEX Technology Fund, which aims to raise €80 million to support deep tech startups primarily in the DACH region (Germany, Austria, and Switzerland). This fund focuses on seed and Series A investments, typically ranging from €1 million to €1.5 million. The partnership combines APEX’s local expertise and network with Amadeus’ extensive global experience in venture capital. APEX Ventures has a diverse portfolio, including companies like contextflow, ImageBiopsy Lab, and Mobius Labs. The firm is known for providing not just capital but also strategic support, leveraging their deep tech expertise and strong networks to help startups scale and succeed​.

Apollo Projects, spearheaded by the Altman brothers—Sam, Jack, and Max—is a venture capital firm that specializes in funding transformative, early-stage companies. With a focus on "moonshots," Apollo targets startups with the potential to disrupt industries and create significant societal impact. Their portfolio boasts notable investments like KoBold Metals, which uses artificial intelligence for mineral exploration, and Glydways, a revolutionary transportation company. Apollo Projects is particularly active in sectors such as AI, renewable energy, and advanced biotechnology, where innovation can drive profound change. The firm typically leads funding rounds, writing substantial checks to support the ambitious goals of its portfolio companies. Apollo's investment strategy is centered around identifying and nurturing startups that are not only innovative but also have a clear vision for large-scale impact. They are especially interested in companies that challenge the status quo and push the boundaries of technology and industry norms. With a seasoned team led by the Altman brothers—each bringing a wealth of experience from their diverse backgrounds—Apollo Projects offers more than just capital. They provide strategic guidance and a deep network of industry connections, making them an invaluable partner for startups aiming to scale quickly and effectively. Entrepreneurs with bold, disruptive ideas often find Apollo Projects to be an ideal ally in their journey to bring groundbreaking technologies to market. This combination of financial backing, expertise, and a shared vision for the future positions Apollo Projects as a pivotal force in the venture capital landscape.

Apollo Health Ventures is a transatlantic venture capital firm with offices in Berlin and Boston, focusing on biotechnology and health tech ventures aimed at extending human healthspan. Established in 2016, Apollo specializes in seed and early-stage investments, particularly in companies that target aging-related diseases and conditions. Their investments focus on developing technologies and therapeutics that address the root causes of aging, helping to maintain cellular health, reduce chronic inflammation, and strengthen the immune system. In 2021, Apollo closed its second fund at $180 million, supported by both existing and new investors. This fund is designed to build and invest in data-driven companies developing breakthrough treatments for age-related diseases. Apollo has co-founded several pioneering companies, including Samsara Therapeutics, which develops autophagy-enhancing molecules, and Aeovian Pharmaceuticals, which focuses on therapeutics to extend healthspan. The firm is led by a team of experienced biotech investors and entrepreneurs, including co-founder Nils Regge, whose ventures have raised over $1 billion in capital. The team also includes Dr. Jens Eckstein, a seasoned venture capitalist with a history of successful biotech investments, and Dr. Marianne Mertens, who brings extensive experience from life sciences and venture investing. With its unique focus on longevity and aging-related innovation, Apollo Health Ventures is at the forefront of biotech ventures aiming to transform healthcare.

Applied Ventures is the venture capital arm of Applied Materials, based in Santa Clara, California. Since its establishment in 2006, the firm has focused on early-stage investments, primarily within deep technology sectors such as semiconductors, energy, advanced materials, and life sciences. Applied Ventures has a global reach, with investments spanning across North America, Europe, Asia-Pacific, and the Middle East. The firm is known for its flexibility, investing up to $100 million annually and actively participating in funding rounds ranging from $10 to $50 million. Its strategy emphasizes supporting startups with disruptive technologies by connecting them to Applied Materials' global ecosystem, which includes industry partners, supply chain resources, and technical expertise. Key portfolio companies include Ayar Labs (optical I/O technology), Rockley Photonics, and TXOne Networks, reflecting its focus on innovations that align with Applied Materials' core strengths in materials engineering and semiconductor technology​. The investment team is led by Anand Kamannavar, who serves as Global Head, alongside key figures such as Brad McManus, John Wei, and Rajesh Ramanujam, all based in Santa Clara. Applied Ventures is stage-agnostic, supporting both early and growth-stage startups as they scale globally, especially those involved in deep tech advancements.

APX is a Berlin-based venture capital firm that focuses on pre-seed investments, supporting startups at the earliest stages. Founded in 2018 as a joint venture between Axel Springer and Porsche, APX is known for backing digital business models and exceptional founding teams across Europe. It has invested in over 185 companies, spanning industries such as fintech, SaaS, consumer services, and mobility. APX is committed to being a long-term partner, often serving as the first investor for many startups. They typically provide initial funding up to €500,000, with follow-on support available as companies grow. In 2023, they launched HEARTFELT, a new fund focused on continuing early-stage investments while managing their existing portfolio. With a hands-on approach, APX offers not just capital but also guidance on sales, operations, and strategic partnerships. Their network of experienced investors and successful entrepreneurs plays a key role in helping startups scale.

Aqua-Spark, based in the Netherlands, is a global investment fund dedicated to sustainable aquaculture. Founded in 2013 by Mike Velings and Amy Novogratz, the fund aims to transform the aquaculture industry by promoting environmental and social sustainability alongside financial returns. Aqua-Spark's mission is to make the production of aquatic life such as fish, shellfish, and plants safe, accessible, and environmentally friendly. The fund manages around $450 million in assets and has invested in 24 companies across the aquaculture value chain, aiming to expand its portfolio to 50-60 companies. Some notable investments include eFishery, an Indonesian aquaculture tech startup, Calysta, a biotech company producing sustainable feed ingredients, and Wanda Fish, which is developing cultivated bluefin tuna. Aqua-Spark focuses on early-stage investments, typically at the Series A stage, and supports companies through to maturity. Their investments are chosen for their potential to generate significant environmental and social impacts while delivering solid financial returns. The fund has a diverse investor base of around 300 investors from over 25 countries.

marArali Ventures, founded in 2017 and based in Bangalore, India, is a venture capital firm focused on early-stage investments in enterprise tech startups. The firm primarily targets companies in India but has also invested in the United States and Singapore. Their investment strategy includes sectors such as artificial intelligence, fintech, healthtech, and high tech. Notable investments by Arali Ventures include Wingman, a conversational AI for sales, and Insent, a B2B enterprise sales platform acquired by ZoomInfo in 2021. Other significant investments include Protecto in business services and Wiz Freight in logistics tech​. Arali Ventures has made 28 investments to date and has achieved notable exits with companies like Insent and Wingman. The firm is currently raising its second seed fund, aiming for $30-40 million, to continue supporting startups in SME tech, industrial automation, and robotics​. Their team, led by Managing Partner Rajiv Raghunandan, provides extensive support to portfolio companies, emphasizing a hands-on approach and deep industry expertise. This supportive environment has made them a highly founder-friendly VC firm.

Aramco Ventures is the corporate venture capital arm of Saudi Aramco, one of the world’s largest integrated energy and chemicals companies. Established in 2012, the fund has grown significantly, recently receiving an additional $4 billion, bringing its total capital to $7.5 billion. This expansion supports Aramco's long-term strategy of investing in technologies critical to energy transition and sustainability. Aramco Ventures operates through several specialized funds, including its Prosperity7 and Sustainability Fund, focusing on sectors such as carbon management, hydrogen, renewables, AI, and advanced materials. The firm has made over 140 investments globally, backing companies like Promethean Particles and Seeq that align with its strategic goals of advancing low-carbon and innovative technologies. The fund is headquartered in Dhahran, Saudi Arabia, and led by CEO Mahdi Aladel. It actively seeks out companies that can contribute to the global energy transition, emphasizing technologies that offer scalable solutions to the challenges facing the energy sector today​.

Arboretum Ventures, headquartered in Ann Arbor, Michigan, is a prominent venture capital firm specializing in the healthcare sector. Founded in 2002 by Jan Garfinkle and Tim Petersen, the firm manages $1 billion across six funds. Arboretum Ventures focuses on capital-efficient investment opportunities in medical devices, life science tools, diagnostics, tech-enabled care delivery, and pharma adjacencies​. The firm has a strong commitment to investing in under-ventured geographies, particularly in the Midwest. Their portfolio includes a variety of innovative companies such as NeuMoDx, which was acquired by QIAGEN, and Fifth Eye, known for its early warning system for patient care​. Arboretum's investment strategy emphasizes supporting startups that aim to reduce healthcare costs while improving patient outcomes. They are active partners, providing strategic guidance and leveraging their extensive network to help portfolio companies succeed. The team includes managing partners Jan Garfinkle, Dr. Tom Shehab, Dan Kidle, and other key members like Paul McCreadie and Marcy Marshall. Overall, Arboretum Ventures stands out for its proactive involvement with entrepreneurs and its focus on transformative healthcare solutions that address significant industry challenges​,

Arch Venture Partners is a powerhouse in venture capital, specializing in early-stage investments in life sciences and technology. With a notable portfolio that includes industry leaders like Grail, Illumina, and Denali Therapeutics, Arch focuses on groundbreaking innovations that transform healthcare and biotech. They have a strong geographic footprint in the United States, with significant investments also in China and the UK. Their investment strategy centers on nurturing disruptive technologies with high-impact potential. Arch Venture Partners typically leads investment rounds, deploying substantial capital to accelerate growth, evidenced by their recent $2.975 billion Fund XII. The firm prioritizes deep scientific expertise and collaborates closely with founders to guide long-term strategic development. Average check sizes vary, but their robust funding capabilities mean they often make sizable commitments. Founded in 1986, Arch is driven by a team of seasoned professionals, including co-founder Robert Nelsen, who has been instrumental in the success of numerous billion-dollar companies. The firm values direct and collaborative approaches from startups, emphasizing the importance of innovative ideas backed by solid research. Overall, Arch Venture Partners stands out for its dedication to pioneering science and technology, its active role in funding and strategy, and its impressive track record of high-profile successes.

Archetype is an early-stage venture capital firm based in New York City, specializing in the cryptocurrency and blockchain sectors. Established to accelerate the decentralized future, Archetype focuses on backing the next generation of crypto founders who are dedicated to creating entirely new markets and disrupting the status quo. The firm brings extensive experience in investing, engineering, operations, policy, and community-building to support innovative builders from the ground up. Archetype's notable investments include companies like Movement Labs, which develops blockchain infrastructure; Stack, a platform for secure digital asset storage; and Lagrange, which focuses on decentralized finance (DeFi) solutions. Other significant investments are in companies such as Ritual, a Web3 platform for content creators, and Socket, a developer of interoperability solutions for blockchain networks. The firm is led by a crypto-native team with diverse backgrounds, including investing, technology, and community engagement, ensuring that their portfolio companies receive comprehensive support. Archetype’s mission is to help founders go from concept to market, leveraging their unique expertise and extensive network to foster success in the decentralized technology landscape.

Archetype is an early-stage venture capital firm that focuses on accelerating the decentralized future, primarily backing startups in the Web3 and cryptocurrency space. Founded in 2021 and based in New York, Archetype is led by founder Ash Egan and a team of experienced professionals from the crypto, investing, and engineering worlds. The firm invests in seed-stage companies, with check sizes typically ranging from $1M to $3M. They also lead many of their funding rounds. Archetype is known for backing founders who are disrupting traditional industries by creating entirely new markets within the decentralized economy. The firm's portfolio includes standout names like Alchemy, Socket, and Mona, all of which focus on cutting-edge technologies in crypto infrastructure, blockchain development, and decentralized applications. Archetype’s investment philosophy is centered on supporting founders with deep technical expertise and a vision for decentralization. They are highly active in the U.S., with a particular focus on startups that bring innovation to financial services, infrastructure, and software development. The firm also provides strategic guidance, leveraging its team’s extensive network within the crypto ecosystem to help startups grow from concept to market-ready products. By combining their expertise in both technology and operations, Archetype positions itself as a critical partner for crypto founders looking to build and scale innovative projects in the decentralized world.

ArcTern Ventures, a Toronto-based venture capital firm with offices in San Francisco and Oslo, is dedicated to tackling climate change through investments in breakthrough technologies. Their focus areas include renewable energy, clean mobility, the circular economy, sustainable food and agriculture, and industrial decarbonization. They manage one of the world's largest dedicated climate tech funds, recently closing their oversubscribed $335 million Fund III​. ArcTern Ventures typically invests in early growth-stage companies that show significant potential for greenhouse gas emission reductions. Their strategy is to back companies with some commercial traction, aiming for those that can rapidly scale revenue and provide immediate climate impact. They often lead investment rounds, with initial checks ranging from $5 million to $10 million, and can commit up to $35 million per company, including follow-on support​. Notable investments by ArcTern Ventures include Clir Renewables, Flashfood, Hydrostor, and Terramera. These companies exemplify ArcTern’s commitment to sustainability and innovation across North America and Europe. The firm values deep research and collaboration, partnering with bold entrepreneurs to drive significant environmental impact.

Aleph VC, founded in 2013 and based in Tel Aviv, specializes in early-stage investments, primarily partnering with Israeli entrepreneurs. With $850 million under management, Aleph focuses on building meaningful companies and impactful global brands across various sectors, including fintech, digital health, cybersecurity, AI, and machine learning. Notable investments by Aleph include Lemonade, a full-stack global insurance company, and Melio, which provides digital payment tools for small businesses. Other prominent portfolio companies include Nexar, a dashcam and edge-AI platform for better driving, and Freightos, a digital freight marketplace. The firm has also seen significant exits, such as the acquisition of Raftt and the public offering of Freightos​. Aleph typically invests between $2 million and $12 million in seed and pre-seed stages, focusing on innovative companies poised for global expansion. The team, led by co-founders Michael Eisenberg and Eden Shochat, leverages their extensive network and expertise to provide strategic guidance and access to global markets, aiming to create long-term value for their portfolio companies.

Argon Ventures, based in Cambridge, Massachusetts, is a pre-seed venture fund focusing on Intelligent Industry Solutions. Founded by Robert Mason and Andrew Feinberg in 2020, Argon Ventures targets early-stage investments in Big Data & Analytics, SaaS, and Software sectors. The firm leverages its deep operational expertise to support founders in building impactful global businesses. Notable investments include companies like EnFi, Cyvl.ai, and PeakMetrics, reflecting Argon's commitment to high-tech, data-driven solutions. Argon Ventures typically leads rounds with an average investment size of around $2M, showing a preference for hands-on engagement from the earliest stages. The firm has built a strong co-investor network, collaborating with prominent investors such as Techstars and Glasswing Ventures. Argon Ventures is characterized by its proactive support in areas like team building, product strategy, and market entry. The team, including seasoned professionals like Bob Mason, brings a combination of technical insight and business acumen, helping startups navigate their growth journeys effectively. With a robust portfolio and a strategic focus on innovative tech solutions, Argon Ventures positions itself as a key player in the venture capital landscape, fostering the next generation of transformative companies.

Armilar Venture Partners is a leading venture capital firm based in Lisbon, Portugal, with a strong international presence. Since its founding in 2000, Armilar has focused on early-stage technology-based companies, particularly in sectors where data, digitization, and connectivity are central. Notable investments include OutSystems, Feedzai, and Vawlt, showcasing their commitment to companies driving digital transformation. Armilar specializes in deep-tech investments, supporting startups that leverage cutting-edge technology to address significant societal challenges. They have a hands-on approach, providing not only capital but also strategic guidance to help their portfolio companies scale effectively. Their investment strategy includes focusing on companies with strong intellectual property and significant market potential, often leading funding rounds to ensure their startups have the resources needed for success. Geographically, while Armilar has a strong focus on Portugal, they are open to investing globally, demonstrating flexibility in finding and supporting the best opportunities regardless of location. Their investment strategy is characterized by patience and long-term support, often leading funding rounds and staying engaged through critical growth phases. The firm has a notable team, including Joaquim Rodrigues, the founder, and managing partners like Nuno Leite and Pedro Santos. These leaders bring extensive experience and a deep understanding of both technology and market dynamics, ensuring they can provide valuable support to their portfolio companies.

Array Ventures, founded in 2015 and based in San Francisco, focuses on early-stage investments in enterprise technology startups. The firm is led by Shruti Gandhi, who leverages her extensive background in software engineering and venture capital to support innovative companies. Array Ventures primarily invests in enterprise SaaS, data, AI, security, infrastructure, and cloud technologies. They typically invest between $250,000 to $2 million in pre-seed and seed rounds, aiming for 8-15% ownership in their portfolio companies. Notable investments by Array Ventures include Simility (acquired by PayPal), CasaOne, Blumira, MadStreet Den, Modal, and Uniform.dev. The firm has a strategic focus on founders with strong technical backgrounds who are leaving lucrative corporate jobs to tackle significant problems. They provide robust support to help these startups grow from initial stages to achieving significant ARR milestones. Array Ventures also has a global investment approach, backing companies that address worldwide markets, including notable investments in Indian and Israeli startups.

Arrington XRP Capital is a dynamic cryptocurrency hedge fund, known for its strategic investments in blockchain technology and digital assets. Founded by Michael Arrington, the former TechCrunch founder, the fund has a significant footprint in the crypto space, backing notable startups such as Nexo, ThunderCore, and Algofi. Their investment portfolio spans various sectors including decentralized finance (DeFi), gaming, and blockchain infrastructure, with companies like Palm Tree Crew, Sipher, and Tinyman showcasing their diverse interests. Arrington XRP Capital primarily focuses on early-stage ventures and Initial Coin Offerings (ICOs), favoring innovative blockchain projects that demonstrate strong potential for growth. The fund operates globally, with no strict geographic limitations, allowing it to capture opportunities across different markets. The investment strategy is rigorous and thoughtful, typically participating in funding rounds with multiple investors to diversify risk. They prefer projects with robust technical foundations and visionary teams, aiming to support the long-term development of the blockchain ecosystem. The fund's typical check size varies, but they are known for leading rounds and providing substantial backing to promising startups​.

Artesian Investments, founded in 2004 by Jeremy Colless, Matthew Clunies-Ross, and John McCartney, is a global alternative investment management firm specializing in venture capital, public and private debt, and impact investment strategies. Based in Sydney, the firm has expanded its reach with offices in Melbourne, Adelaide, Shanghai, Jakarta, Singapore, London, and New York​​. Artesian's notable investments include Instaclustr, PouchNATION, and Regrow Ag. They are particularly active in the Asia-Pacific region, managing over $1.22 billion in assets and boasting more than 600 startup investments​ (Artesian)​. Their investment strategy focuses on early-stage ventures across various sectors, including technology, agrifood, medtech, and AI. Artesian also offers a unique "Venture Capital as a Service" (VCaaS) platform, providing customized investment solutions to corporations, government, and family offices​. The firm places a strong emphasis on ESG (Environmental, Social, and Governance) criteria and impact investing, aiming to deliver sustainable returns while addressing critical global challenges. Artesian is a certified B Corp, underscoring their commitment to positive social and environmental impact. Key team members include Jeremy Colless (CEO), Matthew Clunies-Ross (CIO), and Luke Fay (Partner, Australian Venture Capital). Their diversified team spans multiple continents, bringing extensive expertise and a global perspective to their investment activities

Arthur Ventures, established in 2008 and headquartered in Minneapolis, Minnesota, focuses on investing in early-stage B2B software companies across the U.S. and Canada. They emphasize backing startups located outside Silicon Valley, promoting innovation and growth in diverse regions. Arthur Ventures' portfolio includes a variety of successful companies. Notable investments feature DataCamp, an online data science training platform; Protenus, which offers patient data protection; and ThreatLocker, a zero-trust endpoint security solution. Other significant portfolio companies include Jane.app, a practice management software for health and wellness clinics, and CertifID, a network management software company. The firm has made over 102 investments and has seen 18 exits, with companies like Ionic and TINYpulse achieving successful outcomes. Arthur Ventures focuses on sectors such as SaaS, cybersecurity, fintech, and healthcare IT, providing capital and strategic support to help early-stage companies grow and succeed.

Artiman Ventures, founded in 2001, is a venture capital firm based in Silicon Valley with an additional office in Bangalore. The firm specializes in early-stage investments and adopts a "white space" investment strategy, focusing on sectors with little to no existing competition, thereby seeking to create or disrupt multi-billion dollar markets. Artiman is sector-agnostic and invests across a diverse range of industries including technology, medtech, and communications. Notable investments in Artiman's portfolio include companies like Virsec, which focuses on application security, and Visby Medical, which is revolutionizing disease diagnostics. Other significant investments include ApplyBoard, an AI-enabled marketplace for international students, and CellMax Life, a precision cancer blood-testing company. Geographically, Artiman primarily invests in companies based in the U.S. and India, leveraging its cross-border presence to help startups scale globally. Their investment strategy involves being the first institutional capital, often at the concept phase, and working closely with entrepreneurs to drive strategy, market definition, and execution​. The leadership team at Artiman includes experienced partners like Yatin Mundkur, Amit Shah, and Ajit Singh, who bring deep expertise in technology and life sciences investments. Founder Eric Benhamou, known for his tenure as CEO of 3Com and Palm, leads the team with a strong background in growing and managing tech companies.

Artis Ventures (AV) is a pioneering venture capital fund that specializes in the convergence of technology and biology, a field they have coined "TechBio." This innovative approach leverages advancements in AI, machine learning, and data science to transform healthcare and life sciences, aiming for scalable global impact. Notable investments include Rad AI, which uses artificial intelligence to enhance radiology, and Precision Neuroscience, a leader in neuroplasticity-promoting therapeutics. AV primarily focuses on data-driven life sciences companies that address critical healthcare challenges and are capable of achieving broad, scalable impact. Their industry scope spans oncology, cardiopulmonary, neurology, and beyond, often targeting companies with strong engineering and data science foundations. Geographically, AV invests globally, supporting founders from over 30 countries to foster innovations that can be scaled worldwide. The fund's strategy is centered around investing in early-stage startups with robust technical foundations and significant potential for positive health outcomes. They prefer to lead investment rounds and actively engage with their portfolio companies, offering not just capital but also strategic support and access to a vast network of industry experts. AV's investment team includes prominent figures like Laura Bordewieck Rippy and Luke Antal, who bring extensive experience and a strong track record in venture capital and entrepreneurial support. They are based in San Francisco, a hub for tech and biotech innovation. For startups looking to engage with AV, it's crucial to demonstrate a clear vision for scalable health solutions backed by solid technical expertise. AV values a data-driven approach and is keen on companies that can show potential for significant, measurable impact on global health outcomes.

Ascend Venture Capital, founded in 2015 and headquartered in St. Louis, Missouri, is a beacon of innovation in the Midwest venture capital landscape. The fund primarily invests in early-stage startups across a variety of sectors including AI/ML, SaaS, and commercial products. Notable portfolio companies include Vouched, WhyLabs, and Yoodli, showcasing their commitment to cutting-edge technology and impactful solutions. With a strategic focus on the Midwest, Ascend aims to demonstrate that top-tier venture capital doesn't need to be confined to the coasts. Their investment strategy involves rigorous due diligence and a methodical approach akin to clinical trials. Ascend's first fund aimed to validate their investment thesis, while subsequent funds have stress-tested their systems and expanded their team. The average check size is around $2 million, and they participate in approximately six investment rounds annually. Ascend often uses special purpose vehicles (SPVs) to amplify investments in high-potential portfolio companies, particularly during critical Series A and B stages. The team is led by Dan Conner, the founding general partner, and Yinka Faleti, a key partner, both based in St. Louis. They emphasize human-centered values and transparency, fostering strong, genuine relationships with portfolio companies and investors alike. Ascend’s disciplined approach and focus on integrity and inclusivity have positioned them as a leading venture capital firm in the Midwest​.

Ascent Energy Ventures is a Denver-based venture capital firm focused on the digital transformation of the energy industry. Founded in 2019 by David Forsberg, the firm specializes in late-seed to early Series A investments, targeting startups that leverage digital tools to address modern energy challenges. Ascent’s portfolio emphasizes innovations in sectors like IoT, SaaS, advanced materials, and energy technology, focusing on companies that have demonstrated revenue traction and product-market fit. The firm's strategy centers on identifying and supporting entrepreneurs who apply advanced digital solutions to optimize energy operations, infrastructure, and sustainability. Notable investments include Galatea Technologies, a software firm, and Iron-IQ, a leader in industrial IoT for energy operations. Ascent looks for companies positioned for growth and profitability, often targeting those on the verge of significant scaling. In 2024, Ascent raised $12 million in seed funding to bolster its energy tech portfolio. Led by a team with extensive experience in energy investment and technology, Ascent provides both financial backing and strategic guidance. Key team members include Jim Newell, with over 20 years of venture investment experience, and Chris Lang, who has a background in energy derivatives and advisory roles at major financial institutions. Ascent Energy Ventures is a crucial player in the evolving energy landscape, helping startups secure funding and navigate complex markets to achieve lasting impact..

Aspect Ventures, founded in 2014 by Jennifer Fonstad and Theresia Gouw, is a leading venture capital firm based in Palo Alto, California. The firm focuses on early-stage investments, primarily in Series A rounds, across various sectors including cybersecurity, fintech, digital health, and enterprise software. Notable investments include Gusto, a cloud-based HR management platform; Chime, a digital bank; and Exabeam, a cybersecurity company. Aspect Ventures has had several successful exits such as Forescout Technologies, Imperva, and Trulia.

Assembly Climate Capital is a venture capital firm focused on driving significant climate impact through investments in businesses poised to address the challenges of climate change. The firm primarily invests in Series B and C companies that are ready for commercial deployment and scaling. Their investment philosophy centers on long-term, patient capital with an urgent focus on accelerating climate solutions within the next decade. Assembly Climate Capital brings together expertise in private equity, business strategy, and governance to support its portfolio companies. They emphasize real partnership, providing not just capital but also strategic guidance, mentorship, and access to a wide network of leaders and investors in the climate space. With over 40 years of experience across various sectors, the team is known for its strong track record in value creation and successful exits. Their portfolio includes a mix of climate-focused ventures like Tasman Environmental Markets and Future Super, which align with their mission to foster systemic change and help businesses achieve significant climate impact. Assembly Climate Capital also frequently co-invests with other family offices, further enhancing their collaborative approach to climate investing. Their goal is to support bold management teams in delivering transformative solutions to the most pressing environmental issues of our time.

Astanor Ventures, founded in 2017 by Eric Archambeau and George Coelho, is a Brussels-based venture capital firm specializing in sustainable agrifood technologies. The firm focuses on investing in early-stage, mission-driven companies that address significant social or environmental issues within the agrifood value chain. This includes sectors like regenerative agriculture, bioeconomy, and climate-positive solutions. Astanor recently closed its second venture fund at €360 million, bringing its total assets under management to €800 million. This fund will support innovative solutions aimed at transforming the global food system to be more sustainable and resilient​. The firm boasts an extensive network of entrepreneurs, experts, scientists, and policymakers, which helps identify and nurture groundbreaking technologies. Notable investments include companies that advance autonomous electric agricultural machinery, high-functioning proteins, and genomic sequencing for sustainable food production.

Aster Capital, established in 2000 and based in Paris, is a venture capital firm specializing in Climate Tech investments. The firm focuses on sectors such as energy, mobility, and industry, supporting startups at various stages of development. Aster Capital manages around €500 million in assets and operates globally with offices in Paris, San Francisco, and Tel Aviv. Key investments by Aster include companies like ekWateur, an energy supplier accelerating the energy transition; Betterway, a pioneer in employee mobility solutions; and Iceotope, specializing in liquid cooling technologies for data centers. These investments reflect Aster’s commitment to supporting innovative solutions that contribute to carbon neutrality. Aster recently raised €240 million to invest in energy transition and future mobility projects, underscoring their dedication to driving significant environmental impact through technology. The firm’s strategy involves not only financial investment but also providing extensive support through their "Business Hub" approach, which facilitates business opportunities and partnerships for their portfolio companies​.

Asymmetric Financial is a venture capital firm that focuses on investing in early-stage companies within the fintech, software, and digital health sectors. Founded by Joe McCann in 2022, the firm operates with a unique approach to venture capital, combining deep expertise in technology and finance to support companies that are poised to disrupt traditional industries. Asymmetric Financial aims to identify and back innovative startups that leverage advanced technologies such as artificial intelligence, blockchain, and big data analytics to create new market opportunities. The firm’s investment strategy is centered on providing not only capital but also strategic guidance and operational support. Asymmetric Financial works closely with its portfolio companies to help them scale efficiently, offering assistance in areas such as financial planning, go-to-market strategies, and key performance indicator (KPI) development. This hands-on approach ensures that the startups in their portfolio are well-equipped to navigate the challenges of rapid growth and market competition. Asymmetric Financial is particularly interested in companies that have the potential to generate significant returns while also creating meaningful impact through their innovations. By focusing on sectors that are at the intersection of technology and finance, the firm aims to contribute to the modernization and transformation of the financial services industry.

Asymmetric Capital Partners (ACP) is a venture capital firm focused on backing B2B technology companies from Seed to Series C stages. Founded in 2020 by Rob Biederman, former co-CEO of Catalant Technologies, ACP manages an oversubscribed debut fund of $105 million. The firm targets disruptive businesses in areas like healthcare IT, fintech, marketplaces, and next-gen software, especially those transforming legacy industries and capitalizing on digital innovation. ACP is known for its hands-on approach, leveraging a team of founders and former operators who work closely with startups on strategic growth areas such as hiring, go-to-market strategies, and financial planning. They typically invest between $2M to $10M, with the flexibility to co-invest in larger deals alongside top firms like Andreessen Horowitz and Sequoia Capital. Some notable investments include Firstbase, a remote work platform backed by Andreessen Horowitz, and Clearco, a fintech company. The firm prides itself on being deeply involved with its portfolio companies, providing both operational support and access to a vast network of advisors and industry experts.

Asymmetry Ventures, based in San Francisco, is a prominent early-stage venture capital firm founded by Rob Ness. The firm focuses on investing in transformative startups that have the potential to create significant impact. They have a diverse portfolio of over 280 investments, including notable companies like BillionToOne, Foresight Mental Health, Mast Reforestation (formerly DroneSeed), and Orbit Fab. Asymmetry Ventures is known for their commitment to supporting defensible businesses, particularly in sectors such as artificial intelligence, biotechnology, and aerospace. They typically make initial investments in the range of $2 million and have been involved in notable funding rounds such as Orbit Fab's $10 million raise, which also saw participation from major aerospace players like Northrop Grumman and Lockheed Martin. The firm prides itself on identifying and backing visionary founders and innovative business models, with a strong emphasis on early-stage investments that leverage technology to create natural barriers to entry and generate recurring revenue streams. They also prioritize investments that address significant market needs with scalable solutions. For startups looking to partner with Asymmetry Ventures, demonstrating a strong leadership team and a clear path to market dominance are crucial. The firm's deep network and extensive industry experience provide valuable support and guidance to their portfolio companies, enhancing their potential for growth and success.

At One Ventures is a venture capital firm founded in 2020 by Tom Chi, a founding member of Google X. The firm is dedicated to investing in early-stage startups that are developing disruptive deep tech solutions aimed at making humanity a net positive to nature. With a strong focus on climate tech, At One Ventures has established itself as a significant player in the industry. The firm recently closed its second fund at $375 million, indicating strong investor confidence and a robust commitment to supporting climate-positive innovations. This fund follows their initial $150 million fund and aims to support startups that can dramatically reduce environmental footprints while upending established industrial economics. At One Ventures' investment portfolio includes companies across various sectors such as renewable energy, sustainable agriculture, and advanced materials. Notable investments include Noon Energy, which focuses on long-duration energy storage, and MightyFly, which is developing hybrid electric drone delivery systems. The firm's approach is hands-on, providing strategic guidance in talent acquisition, operations, marketing, IP strategy, and manufacturing. The team at At One Ventures consists of experienced professionals with backgrounds in physical sciences, engineering, manufacturing, and finance, ensuring a deep understanding of the technologies and markets they invest in. They operate globally, with a presence in San Francisco and London, and continue to seek partnerships with entrepreneurs, scientists, and investors who share their vision for a sustainable future.

Atinum Investment, the venture capital arm of Atinum Partners, is a prominent South Korean investment firm with over $450 million in assets under management. The firm focuses on diverse sectors such as deep tech, artificial intelligence, blockchain, advanced robotics, bio-healthcare, and IT components. They actively invest in early-stage to growth-stage startups with significant global market potential. Notable portfolio companies include CryptoQuant, Allganize, and Klook. Atinum Investment has a global reach, particularly focusing on Southeast Asia, with investments in companies like InstaReM and Fast Five, a South Korean co-working space startup. The team at Atinum Investment includes key figures such as Wan Gee Cho, who specializes in deep tech and SaaS investments, and Peter Na, the Regional Head for Southeast Asia, focusing on investments in the region from the Singapore office. Atinum is committed to providing more than just capital by offering strategic guidance and opening doors to potential customers and partners, ensuring the growth and success of their portfolio companies.

Atlantic Bridge, founded in 2004, is a global growth equity technology firm that focuses on investing in deep technology companies across Europe, the UK, and the US. With over €1 billion in assets under management, the firm has a portfolio of 70 companies and has created over 5,000 jobs. Atlantic Bridge is known for its cross-border value-add strategy, helping portfolio companies expand internationally through its offices in Dublin, London, Munich, Paris, and Palo Alto. The firm's portfolio includes notable companies such as SOC Prime, which specializes in enterprise threat detection and response, and Elisity, which combines Zero Trust Network Access with an AI-enabled Software Defined Perimeter. Other significant investments include Siren, an investigative intelligence platform, and Aizon, which optimizes pharmaceutical manufacturing processes using real-time data and predictive models. Atlantic Bridge has achieved successful exits with companies like Navitas Semiconductor, which recently debuted its GaN Power ICs on Nasdaq, and Mitiga, a provider of hybrid managed services for incident response and readiness. The firm is led by experienced industry professionals, including Managing Partners Elaine Coughlan, Brian Long, and Kevin Dillon, who bring extensive expertise in scaling technology companies and executing successful IPOs and M&As.

FoodLabs, founded in 2015 and based in Berlin, Germany, is a prominent venture capital firm dedicated to investing in innovative startups within the food, health, and sustainability sectors. The firm supports companies aiming to revolutionize how we produce, consume, and think about food, with a mission to create sustainable and healthy solutions for the future. FoodLabs has made a significant impact with its diverse portfolio, which includes companies like ChefCoco, a personalized weekly menu service, and Van Heron Labs, which focuses on biotechnology. The firm has been an early investor in some of the most influential European FoodTech startups, such as Infarm, Meatable, Mushlabs, and Sanity Group. These investments span across various stages, from pre-seed to series B and beyond, demonstrating FoodLabs' commitment to nurturing startups through their growth journey. The team at FoodLabs, led by founder Christophe Maire and managing director Patrick Noller, combines deep industry expertise with a strong network to provide strategic support and resources to their portfolio companies. They are particularly focused on sectors like synthetic biology, climate resilience, and health, aiming to address some of the world's most pressing challenges.

Atlantic Labs, based in Berlin, is a prominent early-stage venture capital firm that supports mission-driven founders across Europe. Founded in 2013, the firm has a focus on investing in transformative technology sectors such as climate tech, digital health, future of work, AI and data, industrial automation, mobility and logistics, fintech, and proptech. Atlantic Labs typically invests at the pre-seed stage, with investment sizes ranging from €25,000 to €5 million or more. They have backed over 215 companies, including notable names like SoundCloud, GetYourGuide, Clue, Vimcar, and Cazoo. The firm emphasizes a hands-on approach, providing not only capital but also strategic guidance and access to a robust network of industry experts to help their portfolio companies grow and succeed. The firm's portfolio reflects its diverse focus areas, supporting companies that aim to redefine various industries through innovative solutions. Examples include digital health companies like Clue, AI and data startups such as Mobius Labs, and mobility ventures like GetYourGuide and Cazoo. Atlantic Labs is led by a team of experienced investors and operators who are committed to supporting entrepreneurs throughout their entire journey. This commitment to fostering innovation and growth has established Atlantic Labs as a key player in the European venture capital landscape.

Atlas Venture is a leading biotech venture capital firm focused on creating and building innovative life science companies. With over 30 years of experience, they have incubated over 70 startups and taken 40 companies public, including Intellia Therapeutics, Kymera Therapeutics, and Generation Bio. Atlas specializes in drug discovery and development, emphasizing areas like gene editing, oncology, and immunotherapy. Headquartered in Cambridge, Massachusetts, Atlas primarily targets U.S.-based startups but maintains a global vision, partnering with top scientific minds. They invest early, often leading seed and Series A rounds, with typical check sizes ranging from $5M to $20M. Atlas's approach is hands-on, actively incubating new ventures and co-founding companies with a strong operational focus. Key figures include Jean-François Formela, who has been instrumental in several high-profile exits and IPOs, and focuses on cutting-edge drug discovery technologies. Founders approaching Atlas should focus on breakthrough science with clear therapeutic applications, as the firm seeks to translate groundbreaking research into life-changing medicines.

Atlas Venture is a leading venture capital firm specializing in early-stage investments in biotechnology and life sciences. Founded in 1980 and based in Cambridge, Massachusetts, Atlas Venture has built a robust portfolio by focusing on groundbreaking biotech innovations. The firm has raised multiple funds, including their most recent Fund XIII at $450 million, which emphasizes their commitment to fueling biotech startups from seed stage through to successful exits​. Notable investments in their portfolio include companies like Intellia Therapeutics, Kymera Therapeutics, and Ikena Oncology. These investments highlight Atlas Venture's dedication to developing therapies that address significant unmet medical needs, particularly in oncology and genetic disorders. Intellia Therapeutics, for instance, is renowned for its gene-editing technologies, while Kymera Therapeutics focuses on protein degradation to treat diseases. Atlas Venture has achieved numerous successful exits, such as the acquisitions of IFM Therapeutics by Bristol-Myers Squibb and Novartis, and the IPO of Generation Bio. These exits underscore the firm’s strategic capability in identifying and nurturing high-potential biotech startups to maturity. The firm is led by a team of experienced partners, including Jean-Francois Formela, Jason Rhodes, and David Grayzel, who bring a wealth of expertise in venture capital and life sciences. This team collaborates closely with entrepreneurs to provide not just capital but also strategic guidance and operational support, leveraging their extensive network within the biotech industry. For startups aiming to partner with Atlas Venture, it is crucial to present innovative solutions with strong scientific foundations and clear pathways to address significant medical challenges. The firm values startups that demonstrate potential for substantial clinical impact and scalability within the healthcare sector.

Atomico, founded in 2006 by Skype co-founder Niklas Zennström, is a leading venture capital firm based in London, with additional offices in Paris, Berlin, and Stockholm. The firm focuses on Series A and beyond investments in disruptive technology companies globally. Atomico's notable investments include Klarna, Truecaller, Lime, Hinge Health, and Rovio, which highlight their strong presence in fintech, healthcare, consumer tech, and gaming sectors. Atomico's investment strategy centers around partnering with mission-driven European founders, providing them with not just capital but also extensive operational support through their Growth Acceleration Team. This team assists with scaling operations, strategic planning, and navigating complex market dynamics. Their typical investment range is from $10 million to $50 million, and they often lead rounds, ensuring significant influence in their portfolio companies' trajectories. The firm is known for its diverse team and deep industry expertise. Key figures include Niklas Zennström, CEO and Partner; Chris Barnes, COO; and Thomas Wehmeier, Partner and Head of Insights, all based in London. This diverse leadership team brings a wealth of experience from various sectors, enhancing their ability to support and scale innovative startups. For startups looking to engage with Atomico, it's crucial to showcase innovative solutions with a potential for significant market impact. The firm is particularly interested in technology-driven companies that can leverage shifts in consumer behavior and technological advancements.

ATP Fund, established in 2014 and headquartered in Austin, Texas, is an early-stage venture capital firm that focuses on deep tech investments aimed at advancing human conditions through scientific innovation. The firm specializes in sectors such as artificial intelligence (AI), biotechnology, cleantech, cybersecurity, enterprise software, healthcare, and robotics. ATP Fund is known for its strategic investments in startups that are tackling some of the most challenging and impactful problems of our time. ATP Fund adopts a contrarian and hands-on approach, often partnering with scientific entrepreneurs at the earliest stages of their ventures, sometimes even at the formation stage via their Proto.n initiative. This strategy reflects their commitment to long-term partnerships and their belief in the transformative potential of cutting-edge technologies. The fund's portfolio includes a variety of high-impact companies like Diligent Robotics, which focuses on healthcare robotics, and Infleqtion, a firm that specializes in quantum technology. These investments highlight ATP Fund's dedication to supporting ventures that have the potential to make significant advancements in their respective fields. ATP Fund collaborates with a wide network of co-investors, including notable names like Texas Venture Labs and Osage University Partners. The firm has also seen successful exits, further establishing its reputation as a key player in the deep tech investment landscape.

ATX Venture Partners, established in 2014 and headquartered in Austin, Texas, is an early-stage venture capital firm. The firm primarily invests in disruptive B2B software, APIs, marketplaces, frontier tech, and applications. Notable investments in their portfolio include companies like Aceable, AlertMedia, and Pensa Systems. Focusing on Seed and Series A stages, ATX Venture Partners operates with a strong preference for businesses that are already generating revenue. They actively invest across the United States, with a particular emphasis on the South-Central region. Their strategy involves partnering with entrepreneurs to create transformative technologies, aiming for category-defining outcomes in their respective industries. ATX Venture Partners is led by a team of experienced professionals including co-founders Chris Shonk, Brad Bentz, and Danielle Allen. Chris Shonk, known for his extensive background in both military operations and business, brings a wealth of experience in tech and consumer service investments. Brad Bentz combines expertise in finance, academia, and IT, while Danielle Allen leverages her extensive Wall Street background, focusing on finance and investments, particularly in space and women-led companies. Their investment approach is marked by a hands-on, collaborative ethos, aiming to propel portfolio companies towards larger growth. Entrepreneurs seeking investment are advised to approach ATX Venture Partners through detailed business plans, highlighting innovative solutions and market traction. Their recent investments, like the $1.7 million funding for Light Frame and the $1.9 million for LUXUS, underscore their commitment to fostering growth in cutting-edge sectors. For startups looking to partner with ATX Venture Partners, demonstrating product-market fit and a clear path to revenue generation is key.

AU21 Capital is a venture capital firm focused on investing in blockchain technology. Founded in 2017, AU21 Capital combines decades of executive and operational experience from industry leaders like Huobi and Galaxy Digital. The firm invests primarily in early-stage and seed investments, supporting companies that are pushing the boundaries of blockchain technology. AU21 Capital’s portfolio includes notable projects such as Axie Infinity, Injective, Marlin, Cere, Covalent, Casper Labs, Serum, Fantom, Harmony, Iotex, Coin98, Polkadot, and Star Atlas. The firm is known for its deep involvement in the development and growth of these companies, often collaborating with top exchanges and launchpads to bring innovative products to market. The leadership team at AU21 Capital leverages its extensive network and expertise to provide strategic guidance, business development, and market positioning for its portfolio companies. This hands-on approach ensures that the startups they back are well-equipped to navigate the challenges of the blockchain industry and achieve significant growth.

Audacia is a Paris-based private equity and venture capital firm, founded in 2006 by Charles Beigbeder. The firm focuses on a range of investment strategies, including venture capital, growth capital, and buyouts, primarily targeting high-tech, real estate, and consumer sectors. With a strong emphasis on innovation and technological advancement, Audacia has built a diverse portfolio of over 229 investments, including companies like Gamestream and Multiverse Computing. Audacia is particularly active in France, which accounts for the majority of its investments, though they also have a presence in other regions like the United Kingdom. The firm’s approach involves leading early-stage and Series A funding rounds, supporting startups through to later stages of growth. Audacia’s investment philosophy centers on backing visionary entrepreneurs and innovative companies that have the potential to disrupt their respective industries. The firm is led by a seasoned team of 20 professionals, including key figures such as Charles Beigbeder, Cedric James, and Vincent Brillault, who bring extensive experience in both the investment and operational aspects of the business. With its strategic focus and deep expertise, Audacia continues to play a significant role in shaping the European venture capital landscape​.

Audacious Ventures is a venture capital firm dedicated to supporting the world's most ambitious founders from the earliest stages of their entrepreneurial journeys. Founded in 2020, the firm has quickly made a name for itself with its unique approach that blends traditional seed-stage investing with a strong emphasis on talent acquisition for its portfolio companies. In April 2024, Audacious announced its $150 million second fund, Audacious 2.0, which continues its mission to invest in sectors such as AI, fintech, healthcare, construction tech, and climate tech. What sets Audacious apart is its deep focus on helping founders build A+ teams, particularly in critical areas like engineering, sales, and marketing. Half of Audacious' team comprises experienced recruiters who actively run searches for portfolio companies, ensuring they attract top-tier talent as they scale. This hands-on support reflects the firm’s belief that startup success hinges on exceptional teams and large market opportunities. Audacious Ventures has invested in several high-growth companies, including Vartana, Multiverse, Suppli, and Ignition. These investments underscore the firm’s commitment to backing startups that have the potential to become industry leaders. Unlike many venture firms, Audacious does not take board seats, preferring instead to focus on providing value through strategic hiring support and then stepping back to let founders lead their companies to success​.

Augment Ventures is a venture capital firm based in Ann Arbor, Michigan, specializing in early-stage investments across North America. The firm, founded in 2011 by Sonali Vijayavargiya, focuses on companies at the intersection of digital innovation and data utilization, particularly in sectors such as supply chain, fintech, industry 4.0, health tech, proptech, climate tech, B2B, and SaaS​. Notable investments by Augment Ventures include companies like LLamasoft, which was sold to Coupa Software for $1.5 billion, Optilogic, a cloud-native supply chain software solution, and Fluree, a platform recognized among the coolest data management companies​. Their portfolio also features innovative companies like Pair Team, Secro, Guardhat, and Crowdz, which span diverse industries from healthcare and fintech to supply chain and industrial safety. Augment Ventures emphasizes partnering with mission-oriented founders and diverse teams to address significant, real-world challenges. They provide not just capital but also strategic guidance and operational support to help startups scale and succeed in a constantly evolving global economy​.

Auriga Partners is a Paris-based venture capital firm established in 1998. The firm specializes in early-stage investments across various sectors, including information technology, life sciences, and cybersecurity. Auriga Partners has a strong focus on supporting high-potential ventures in Europe, North America, and Israel. Notable investments by Auriga Partners include Vade Secure, Nexthink, and Exeliom Biosciences. Vade Secure, a leader in predictive email defense, and Nexthink, a prominent analytics software provider, highlight Auriga’s commitment to backing innovative tech companies. Exeliom Biosciences, a biotech firm focused on the development of microbiome therapeutics, demonstrates their investment in life sciences. Auriga Partners has a robust portfolio with over 171 investments and 77 exits, reflecting their extensive experience and successful track record in venture capital. Their approach involves not only providing capital but also leveraging their expertise and network to support the growth and development of their portfolio companies. The team at Auriga Partners includes seasoned professionals like Philippe Granger, Mathieu Chatain, and Nabil Gharios, who bring significant industry knowledge and investment experience.